What To Expect From A Venture Capitalist The more important question is, ‘What can I expect out of a good […]

Is ImClone Out of the Woods? If the FDA approves its Erbitux anticancer treatment, as S&P expects, the biotech’s volatile

What’s in a Drug Name? Did you ever wonder at the bizarre brand names born by your favorite medicines? If

What’s in a Drug Name? Did you ever wonder at the bizarre brand names born by your favorite medicines? If

Rise in biotech lawsuits Biotech companies were served with 17 percent of all U.S. shareholder suits last year, according to

Agriculture Department looks at revamping biotech rules Worried about the inadvertent spread of new bioengineered plants that produce drugs and

Making Way for Designer Insects The insect world could shortly undergo a genetic makeover in the laboratory. Scientists are at

Biotech firms urge Canada to uphold canola patent Representatives for scientists and biotech firms warned Tuesday that companies could abandon

Biotech Limits Found Lacking Techniques for limiting the spread of genetically engineered salmon, corn and other organisms are still in

FDA’s economist in chief Foes and friends of Mark McClellan agree on at least one point: The Food and Drug